Capital Fund Management (CFM)’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-13,756
| Closed | -$784K | – | 809 |
|
|
2022
Q2 | $784K | Buy |
+13,756
| New | +$784K | 0.01% | 502 |
|
|
2020
Q4 | – | Sell |
-1,540
| Closed | -$383K | – | 798 |
|
|
2020
Q3 | $383K | Sell |
1,540
-1,279
| -45% | -$318K | ﹤0.01% | 505 |
|
|
2020
Q2 | $979K | Buy |
+2,819
| New | +$979K | 0.02% | 318 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1043 |
|
|
2018
Q4 | – | Sell |
-47,143
| Closed | -$43.1M | – | 1057 |
|
|
2018
Q3 | $43.1M | Buy |
+47,143
| New | +$43.1M | 0.24% | 23 |
|
|
2018
Q2 | – | Sell |
-563
| Closed | -$897K | – | 1144 |
|
|
2018
Q1 | $897K | Buy |
+563
| New | +$897K | 0.01% | 585 |
|
|
2016
Q4 | – | Sell |
-5,933
| Closed | -$1.53M | – | 1037 |
|
|
2016
Q3 | $1.53M | Buy |
+5,933
| New | +$1.53M | 0.01% | 456 |
|
|
2016
Q1 | – | Sell |
-747
| Closed | -$189K | – | 1023 |
|
|
2015
Q4 | $189K | Buy |
+747
| New | +$189K | ﹤0.01% | 705 |
|
|
2015
Q3 | – | Sell |
-8,045
| Closed | -$1.51M | – | 830 |
|
|
2015
Q2 | $1.51M | Buy |
+8,045
| New | +$1.51M | 0.02% | 334 |
|
|
2013
Q3 | – | Sell |
-2,167
| Closed | -$375K | – | 925 |
|
|
2013
Q2 | $375K | Buy |
+2,167
| New | +$375K | 0.01% | 691 |
|